Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

This bill amends existing New Jersey law to clarify and expand the rules for prescribing Schedule II controlled dangerous substances through telemedicine and telehealth. It removes the requirement for an in-person examination before prescribing these medications, with some exceptions, and outlines specific requirements for providers, including licensing, record-keeping, and patient communication. The bill also addresses prescribing stimulants to minors and provides flexibility for certain patient populations, such as those undergoing cancer treatment or hospice care.